Kathryn MacFarlane
Follow
Get notifications in MyBN when activity occurs.
Kathryn MacFarlane
Non-Executive Director / Mayne Pharma Group
Dr Kathryn MacFarlane has over 30 years of experience in the pharmaceutical industry.
She is the founder and managing partner of SmartPharma LLC, offering commercial and strategic consulting services to pharmaceutical companies.
Prior to that, Dr MacFarlane was the chief commercial officer of Agile Therapeutics; vice president of women’s health care marketing, sales and new product planning at Warner Chilcott; and senior director of marketing at Parke-Davis (now Pfizer).
Dr MacFarlane has a Bachelor of Science and Doctor of Pharmacy from Purdue University, and completed a Postdoctoral Fellowship with Rutgers University and Hoffmann- LaRoche.
She is the founder and managing partner of SmartPharma LLC, offering commercial and strategic consulting services to pharmaceutical companies.
Prior to that, Dr MacFarlane was the chief commercial officer of Agile Therapeutics; vice president of women’s health care marketing, sales and new product planning at Warner Chilcott; and senior director of marketing at Parke-Davis (now Pfizer).
Dr MacFarlane has a Bachelor of Science and Doctor of Pharmacy from Purdue University, and completed a Postdoctoral Fellowship with Rutgers University and Hoffmann- LaRoche.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 82nd | Mayne Pharma Group | 105% | -13% |
| 357th | PWR Holdings | 24% | 29% |
| 594th | Regal Investment Fund | 5% | |
| 1001st | Retail Food Group | -19% | -23% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 348th |  | Mayne Pharma Group | $193.0m |
| 413th |  | PTB Group | $125.2m |
| 414th | | Regal Investment Fund | $124.8m |
| 417th | | Retail Food Group | $120.7m |
| 418th | | PWR Holdings | $120.2m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, Mayne Pharma Group | 08 Feb 2022 |
